FILE PHOTO: The logo of Lupin, India's No. 2 drugmaker, is seen on the facade of its pharmaceutical plant in Verna FILE PHOTO: The logo of Lupin, India's No. 2 drugmaker, is seen on the facade of its ...
Under the terms of the separate settlement agreements with Lupin and Zydus, Astellas will receive a total of $60 million to resolve the litigations from the two companies. In addition, Astellas will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results